Kamiya Mehla to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Kamiya Mehla has written about Xenograft Model Antitumor Assays.
Connection Strength
0.342
-
Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors. Cancer Immunol Immunother. 2018 Mar; 67(3):445-457.
Score: 0.139
-
Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth. Oncotarget. 2015 Dec 01; 6(38):41146-61.
Score: 0.121
-
Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Gastroenterology. 2021 11; 161(5):1584-1600.
Score: 0.045
-
Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinoma. Oncogene. 2019 06; 38(26):5308-5320.
Score: 0.038